Joe Anderson

Partner at Sofinnova Partners

Joe Anderson is a Partner at Sofinnova Partners, a leading European venture capital firm specializing in life sciences investments. Here are some key details about Joe Anderson:

Professional Background

Joe Anderson joined Sofinnova Partners in 2020 as a Partner in their Crossover Strategy.1 3
He has over 30 years of experience in the healthcare and life sciences industry.1
Prior to Sofinnova, he was co-founder and CEO of Arix Bioscience plc, a venture capital firm listed on the London Stock Exchange.2
He previously spent 12 years as a partner at Abingworth LLP, where he led venture investments in public companies and helped form the firm's public equities fund.1 2

Investment Experience

As an investor and board member, Joe has helped companies with financings, IPOs, and M&As.1
Some notable companies he has worked with include Algeta (sold to Bayer), Amarin Corp (Nasdaq-listed), Autolus Therapeutics (Nasdaq-listed), and Cytos Biotechnology (merged with Kuros).1 2

Early Career

Joe began his career at the Wellcome Trust, where he became head of the strategy group.1 2
He later moved into equities research as a pharmaceutical analyst at Dresdner Kleinwort Benson.2
He also worked in fund management, managing a global healthcare and biotechnology fund at First State Investments before transitioning to venture capital in 2004.2

Education

Joe holds a Ph.D. in Biochemistry.2

At Sofinnova Partners, Joe Anderson brings his extensive experience to help support and develop innovative life sciences companies, particularly in later-stage investments through the firm's Crossover Fund.3